Summary
- Current Price
- As of today, DMRA price is $29.92, up +0.13% on
- Current Price All-Time High
- DMRA price is currently -93.35% below its historical high of $449.75 set on
- Market Cap
- DMRA current market cap is $2B, up +42549.10% over the past 365 days
- Revenue
- DMRA current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DMRA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Damora Therapeutics, Inc. |
| Ticker | NASDAQ: DMRA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | galecto.com |
| Employees | 5 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $29.92 | |
| Price, 1D Change | +0.13% | |
| $2B | ||
| - | ||
| - | ||
| 1.95 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$152.99 | ||
| EPS, 1Y Change | -725.75% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | GLTO | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$152.99 | ||
| EPS Estimate | -$1.76 | N/A |
| EPS Est. Change | +98.85% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $29.92 | |
| Price Target | $45.00 | - |
| Price Tgt. Change | +50.40% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$18.53 | - | |
| -$0.96 | -$152.99 | -15,908.13% | |
| -$1.76 | N/A | +98.85% | |
| -$2.08 | N/A | +98.64% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $29.92 | |
| $24.24 | ||
| $26.43 | ||
| - | ||
| - | ||
| - | ||
| 1.95 | ||
| $2.21 | ||
| 54.31 | ||
| 44.88% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$152.99 | ||
| -$34.00K | ||
| - | ||
| -$36.56M | ||
| - | ||
| -$209.84M | ||
| - | ||
| -$36.53M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 12.98 | ||
| 12.98 | ||
| - | ||
| - | ||
| 49.45 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 4.86 | ||
| -20.26 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$175.87M | ||
| $257.62M | ||
| $260.53M | ||
| $260.42M | ||
| $21.49M | ||
| $20.07M | ||
| $1.41M | ||
| $15.00K | ||
| $444.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $209.84M | ||
| $36.53M | ||
| $34.00K | ||
| $9.69M | ||
| $34.00K | ||
| $0.00 | ||
| $50.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$6.73M | ||
| -$17.37M | ||
| $266.84M | ||
| $0.00 | ||
| -$6.73M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| Jefferies | ||
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| HC Wainwright & Co. | ||
| Wedbush | ||
| RBC Capital | ||
| Evercore ISI Group | ||
| UBS | ||
| Guggenheim | → |
Analyst sentiment
Institutional ownership
Screeners with DMRA
FAQ
- What is the ticker symbol for Damora Therapeutics, Inc.?
- The ticker symbol for Damora Therapeutics, Inc. is NASDAQ:DMRA
- Does Damora Therapeutics, Inc. pay dividends?
- No, Damora Therapeutics, Inc. does not pay dividends
- What sector is Damora Therapeutics, Inc. in?
- Damora Therapeutics, Inc. is in the Healthcare sector
- What industry is Damora Therapeutics, Inc. in?
- Damora Therapeutics, Inc. is in the Biotechnology industry
- What country is Damora Therapeutics, Inc. based in?
- Damora Therapeutics, Inc. is headquartered in United States
- When did Damora Therapeutics, Inc. go public?
- Damora Therapeutics, Inc. initial public offering (IPO) was on October 29, 2020
- Is Damora Therapeutics, Inc. in the S&P 500?
- No, Damora Therapeutics, Inc. is not included in the S&P 500 index
- Is Damora Therapeutics, Inc. in the NASDAQ 100?
- No, Damora Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Damora Therapeutics, Inc. in the Dow Jones?
- No, Damora Therapeutics, Inc. is not included in the Dow Jones index
- When was Damora Therapeutics, Inc. last earnings report?
- Damora Therapeutics, Inc.'s most recent earnings report was on August 11, 2025
- When does Damora Therapeutics, Inc. report earnings?
- The next expected earnings date for Damora Therapeutics, Inc. is August 11, 2026
Data Sources & References
- DMRA Official Website galecto.com
- DMRA Profile on Yahoo Finance finance.yahoo.com/quote/DMRA
- DMRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dmra